ABSTRACT
PURPOSE OF REVIEW: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in childhood. Recent studies report genetic susceptibility variants for PFAPA syndrome and the efficacy of tonsillectomy in a broader cohort of patients with recurrent stereotypical fever. In this review, we highlight the findings of these studies and what they may reveal about the pathogenesis of PFAPA. RECENT FINDINGS: Newly identified genetic susceptibility loci for PFAPA suggest that it is a complex genetic disorder linked to Behçet's disease and recurrent aphthous ulcers. Patients who have PFAPA with some features of Behçet's disease have been reported. Moreover, the efficacy of tonsillectomy has now been described in patients who do not meet the full diagnostic criteria for PFAPA, although the immunologic profile in the tonsils is different from those with PFAPA. Factors that predict response to tonsillectomy are also reported. SUMMARY: These findings highlight the heterogeneous phenotypes that may be related to PFAPA due to common genetic susceptibility or response to therapy. These relationships raise questions about how to define PFAPA and highlight the importance of understanding of the genetic architecture of PFAPA and related diseases.
Subject(s)
Behcet Syndrome , Lymphadenitis , Pharyngitis , Stomatitis, Aphthous , Humans , Stomatitis, Aphthous/genetics , Genetic Predisposition to Disease , Pharyngitis/genetics , Lymphadenitis/geneticsABSTRACT
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in children. The disease appears to cluster in families, but the pathogenesis is unknown. We queried two European-American cohorts and one Turkish cohort (total n = 231) of individuals with PFAPA for common variants previously associated with two other oropharyngeal ulcerative disorders, Behçet's disease and recurrent aphthous stomatitis. In a metaanalysis, we found that a variant upstream of IL12A (rs17753641) is strongly associated with PFAPA (OR 2.13, P = 6 × 10-9). We demonstrated that monocytes from individuals who are heterozygous or homozygous for this risk allele produce significantly higher levels of IL-12p70 upon IFN-γ and LPS stimulation than those from individuals without the risk allele. We also found that variants near STAT4, IL10, and CCR1-CCR3 were significant susceptibility loci for PFAPA, suggesting that the pathogenesis of PFAPA involves abnormal antigen-presenting cell function and T cell activity and polarization, thereby implicating both innate and adaptive immune responses at the oropharyngeal mucosa. Our results illustrate genetic similarities among recurrent aphthous stomatitis, PFAPA, and Behçet's disease, placing these disorders on a common spectrum, with recurrent aphthous stomatitis on the mild end, Behçet's disease on the severe end, and PFAPA intermediate. We propose naming these disorders Behçet's spectrum disorders to highlight their relationship. HLA alleles may be factors that influence phenotypes along this spectrum as we found new class I and II HLA associations for PFAPA distinct from Behçet's disease and recurrent aphthous stomatitis.
Subject(s)
Behcet Syndrome/genetics , Fever/genetics , Genetic Predisposition to Disease , Lymphadenitis/genetics , Pharyngitis/genetics , Stomatitis, Aphthous/genetics , Alleles , Behcet Syndrome/immunology , Child , Cohort Studies , Fever/immunology , Genes, MHC Class I/genetics , Genes, MHC Class I/immunology , Genes, MHC Class II/genetics , Genes, MHC Class II/immunology , Genetic Loci/immunology , Humans , Lymphadenitis/immunology , Pharyngitis/immunology , Polymorphism, Single Nucleotide , Risk Factors , Stomatitis, Aphthous/immunology , SyndromeABSTRACT
Periodic fever/aphthosis/pharyngitis/adenitis (PFAPA) syndrome was initially described in a small cohort of American children [...].
Subject(s)
Lymphadenitis , Lymphadenopathy , Microbiota , Pharyngitis , Stomatitis, Aphthous , Child , Humans , Stomatitis, Aphthous/genetics , Lymphadenitis/genetics , Pharyngitis/genetics , SyndromeABSTRACT
Fever is a common symptom of infection in children. Periodic fever syndromes are less common but more complex. One of these Periodic fever syndromes is PFAPA (periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis) syndrome which is known as the most benign syndromes. The cause of this disease is unknown. Various factors, including environmental and genetic factors, are involved in the development of this disease. In this study, the association of rs13075270 and rs13092160 polymorphisms were investigated in CCR1 and CCR3 genes with susceptibility to this syndrome in the Chinese population. In this regard, 38 patients with PFAPA syndrome and 100 healthy individuals were selected. After DNA sampling and extraction, polymorphisms of CCR1 and CCR3 receptor genes were examined by the PCR-RFLP method. Findings were analyzed using SPSS software version 22 with a significant level of P <0.05. The frequency of T/T genotype rs13092160 polymorphism in the patient and control groups was 78.95% and 83%, respectively, C/T genotype was 21.05% and 17% (P = 0.421). The frequency of the C/C genotype was 0 in both groups. Regarding rs13075270 polymorphism, the frequency of T/T genotype in patient and control groups was 15.79% and 81%, C/T genotype was 78.95% and 18% and C/C genotype was 5.26% and 1%, respectively (P<0.05). Thus, in rs13075270 polymorphism, the C/T genotype was associated with the risk of PFAPA syndrome (P<0.05), but rs13092160 polymorphism did not show a significant difference between individuals with PFAPA syndrome and controls.
Subject(s)
Familial Mediterranean Fever/genetics , Receptors, CCR1/genetics , Receptors, CCR3/genetics , Child , Fever/complications , Fever/genetics , Humans , Lymphadenitis/complications , Lymphadenitis/diagnosis , Lymphadenitis/genetics , Pharyngitis/diagnosis , Pharyngitis/genetics , Stomatitis, Aphthous/complications , Stomatitis, Aphthous/diagnosis , Stomatitis, Aphthous/genetics , SyndromeABSTRACT
This study was conducted to investigate the relationship between clinic features and Mediterranean fever gene (MEFV) variants in patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome. In total, 167 patients with PFAPA syndrome were included in the study. Female:male ratio of the patients was 0.75 (72 females, 95 males). In total 59.9% of patients with PFAPA had at least one MEFV variant and the most common heterozygous variants were M694V in 29.3% of the patients (40/167), E148Q in 8.3% (14/167), and V726A in 7.1% (12/167). The median age at the disease onset was significantly higher and the median duration of the episodes was significantly lower in patient with variants in exon 10 comparing to the others (both p = 0.01). Similarly, the median age at the disease onset was significantly higher (p = 0.01) and the median duration of the episodes was significantly lower (p = 0.04) in patient with MEFV variants than in the remaining patients. There were no significant differences according to the genotypes of the patients in terms of both treatment response and the frequency of clinical findings.Conclusion: In PFAPA syndrome, MEFV variants may be a modifier for disease onset and attack duration. What is Known: ⢠Due to periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome having clinical findings resembling familial Mediterranean fever (FMF), it can be difficult to distinguish PFAPA syndrome and FMF especially in endemic regions for FMF. ⢠Underlying MEFV mutations could affect the periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome's clinical presentation and response to treatment. What is New: ⢠Having one of the underlying MEFV variants is related to later disease onset and shorter episode duration in patients with PFAPA syndrome.
Subject(s)
Lymphadenitis , Pharyngitis , Stomatitis, Aphthous , Female , Fever/etiology , Humans , Lymphadenitis/diagnosis , Lymphadenitis/genetics , Male , Pharyngitis/genetics , Pyrin/genetics , Stomatitis, Aphthous/geneticsABSTRACT
Group A Streptococcus (GAS) is the etiologic agent of numerous high-morbidity and high-mortality diseases. Infections are typically highly proinflammatory. During the invasive infection necrotizing fasciitis, this is in part due to the GAS protease SpeB directly activating interleukin-1ß (IL-1ß) independent of the canonical inflammasome pathway. The upper respiratory tract is the primary site for GAS colonization, infection, and transmission, but the host-pathogen interactions at this site are still largely unknown. We found that in the murine nasopharynx, SpeB enhanced IL-1ß-mediated inflammation and the chemotaxis of neutrophils. However, neutrophilic inflammation did not restrict infection and instead promoted GAS replication and disease. Inhibiting IL-1ß or depleting neutrophils, which both promote invasive infection, prevented GAS infection of the nasopharynx. Mice pretreated with penicillin became more susceptible to GAS challenge, and this reversed the attenuation from neutralization or depletion of IL-1ß, neutrophils, or SpeB. Collectively, our results suggest that SpeB is essential to activate an IL-1ß-driven neutrophil response. Unlike during invasive tissue infections, this is beneficial in the upper respiratory tract because it disrupts colonization resistance mediated by the microbiota. This provides experimental evidence that the notable inflammation of strep throat, which presents with significant swelling, pain, and neutrophil influx, is not an ineffectual immune response but rather is a GAS-directed remodeling of this niche for its pathogenic benefit.
Subject(s)
Nasopharynx/immunology , Receptors, Interleukin-1 Type I/immunology , Signal Transduction/immunology , Streptococcal Infections/immunology , Streptococcus pyogenes/pathogenicity , Animals , Anti-Bacterial Agents/adverse effects , Bacterial Proteins/genetics , Bacterial Proteins/immunology , Caspase 1/genetics , Caspase 1/immunology , Chemotaxis, Leukocyte , Exotoxins/genetics , Exotoxins/immunology , Inflammation , Interleukin 1 Receptor Antagonist Protein/pharmacology , Interleukin-1beta/immunology , Mice , Nasopharynx/microbiology , Neutrophils/immunology , Pharyngitis/genetics , Pharyngitis/immunology , Pharyngitis/microbiology , Receptors, Interleukin-1 Type I/genetics , Signal Transduction/drug effects , Streptococcal Infections/genetics , Streptococcal Infections/microbiology , Streptococcus pyogenes/drug effects , Streptococcus pyogenes/genetics , Streptococcus pyogenes/growth & development , Virulence/drug effects , Virulence/geneticsABSTRACT
OBJECTIVE: The new classification criteria for the hereditary recurrent fever (HRF) syndrome [cryopyrin-associated periodic syndrome (CAPS), TNF-α receptor-associated periodic syndrome (TRAPS), FMF and mevalonate kinase deficiency] have been published recently. These criteria define two core sets of criteria for each HRF: mixed criteria, including genetic and clinical variables, and clinical criteria, relying on clinical variables only. Our aim was to validate the criteria for HRF in an independent cohort, the JIR Cohort database, an international repository of systemic inflammatory diseases. METHODS: We enrolled patients with HRF, periodic fever, adenitis, pharyngitis and aphthous stomatitis syndrome (PFAPA) and syndrome of undefined recurrent fever (SURF). A score ranging from zero to two was attributed to their respective genotypes: zero (no mutation), one (non-confirmatory genotype) or two (confirmatory genotype). The criteria were applied to all patients based on genotype scoring. The treating physician's diagnosis served as the gold standard for the determination of specificity. RESULTS: We included 455 patients. The classification criteria showed excellent specificity for CAPS and TRAPS (98% specificity each), fair specificity for FMF (88%), but poor specificity for mevalonate kinase deficiency (58%). Sub-analysis showed excellent accuracy of the mixed criteria for all four HRFs. Misclassification was mainly attributable to clinical criteria sets, with false-positive patients in all four HRF clinical criteria sets. CONCLUSION: This study represents the final validation step of the HRF classification criteria as recommended by the ACR. Genetic data appear to be necessary to classify patients with HRF correctly.
Subject(s)
Hereditary Autoinflammatory Diseases/classification , Cohort Studies , Cryopyrin-Associated Periodic Syndromes/classification , Cryopyrin-Associated Periodic Syndromes/genetics , Databases, Factual , Familial Mediterranean Fever/classification , Familial Mediterranean Fever/genetics , Genotype , Hereditary Autoinflammatory Diseases/genetics , Humans , Lymphadenitis/genetics , Mevalonate Kinase Deficiency/classification , Mevalonate Kinase Deficiency/genetics , Mutation , Pharyngitis/genetics , Sensitivity and Specificity , Stomatitis, Aphthous/genetics , SyndromeABSTRACT
PURPOSE OF REVIEW: This review aims at summarizing the current knowledge of A20 haploinsufficiency and other paediatric inflammatory disorders with mucosal involvement. RECENT FINDINGS: A20 haploinsufficiency is a newly described autoinflammatory disease caused by loss-of-function mutations in TNFAIP3 that result in the activation of the nuclear factor (NF)-kB pathway. Patients may present with dominantly inherited, early-onset systemic inflammation and a Behçet-like disease, or a variety of autoinflammatory and autoimmune features. In Behçet disease, recent literature provides insights into genetic susceptibility and emerging treatment options; in addition, the first paediatric classification criteria were published. Recent advances in periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA) suggest that the disease has a complex underlying genetic mechanism and in some cases is inherited in an autosomal dominant pattern with reduced penetrance phenotype in many family members. Activation of the pyrin inflammasome through the RoA signalling pathway uncovers an interesting molecular connection between hyperimmunoglobulinemia D syndrome and familial Mediterranean fever. The description of new monogenic types of inflammatory bowel disease (IBD) may provide novel insights into disease pathogenesis. Finally, recent studies highlighted the role of gut microorganisms and dysbiosis in IBD. SUMMARY: Monogenic diseases such as A20 haploinsufficiency may help to advance our understanding of disease pathogenesis and to develop targeted therapies for more common, multifactorial disorders with mucosal inflammation.
Subject(s)
Haploinsufficiency/genetics , Hereditary Autoinflammatory Diseases/genetics , Tumor Necrosis Factor alpha-Induced Protein 3/genetics , Behcet Syndrome/genetics , Child , Familial Mediterranean Fever/genetics , Genetic Predisposition to Disease , Humans , Lymphadenitis/genetics , Mevalonate Kinase Deficiency/genetics , Mutation , Pharyngitis/genetics , Pyrin/genetics , Stomatitis, Aphthous/geneticsABSTRACT
PURPOSE OF REVIEW: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is considered the most common periodic fever syndrome of childhood. Although it was first described three decades ago, the pathogenesis has been poorly understood. Recent studies on the heritability and immunology of the disorder have begun to shed light into the mechanisms of this autoinflammatory disorder. This review will focus on the pathogenesis of PFAPA, especially as it pertains to the genetic susceptibility, tonsillar immunology, and the role of the microbiome. RECENT FINDINGS: Recent literature provides insights into the heritability, potential genetic modifiers, and the immunologic and microbiological profile of the tonsils in this syndrome. SUMMARY: Evidence is mounting that PFAPA is inherited as a complex genetic disease. Furthermore, tonsillectomy is curative in the majority of patients, including those who do not meet the complete clinical criteria for PFAPA. The tonsils in PFAPA patients may exhibit unique immunologic and microbiological features. The goal of this review is to outline these new developments.
Subject(s)
Autoimmunity , Fever , Lymphadenitis , Microbiota , Palatine Tonsil/microbiology , Pharyngitis , Stomatitis, Aphthous , Fever/complications , Fever/genetics , Fever/immunology , Genetic Predisposition to Disease , Humans , Lymphadenitis/complications , Lymphadenitis/genetics , Lymphadenitis/immunology , Palatine Tonsil/immunology , Pharyngitis/complications , Pharyngitis/genetics , Pharyngitis/immunology , Stomatitis, Aphthous/complications , Stomatitis, Aphthous/genetics , Stomatitis, Aphthous/immunology , SyndromeABSTRACT
BACKGROUND & OBJECTIVES: Rheumatic fever (RF) and rheumatic heart disease (RHD) are the autoimmune sequelae caused by Group A Streptococcus. RHD still remains a major concern in the developing countries due to its poor diagnosis, lack of vaccines and social awareness among population. This study was aimed to identify the plausible early- and late-stage disease markers associated with RF/RHD. METHODS: A total of 84 patients with confirmed pharyngitis (n=18), RF (n=23) and RHD (n=43) were included in the comparative analysis of different factors involved in host-pathogen interaction during RF/RHD pathogenesis. RESULTS: This study revealed high titre of serum antistreptolysin O (ASO) antibody in pharyngitis compared to RF and RHD patients, whereas procollagen type 1 C-peptide (PICP) level was elevated in RHD which showed an inverse correlation with serum ASO titre. The significant elevation of serum anti-peptide associated with RF (PARF) antibody in RF patients was correlated as a probable stage-specific determinant. In addition, pro-inflammatory cytokine profile revealed high levels of interleukin-12 (IL-12)/IL-23p40, IL-17A in RF, whereas IL-6 concentration was higher in RHD compared to healthy controls. INTERPRETATION & CONCLUSIONS: The overall assessment of the factors/ disease markers involved in host-pathogen interaction in RF/RHD may be suggestive of plausible disease marker in different groups of patients. Further studies with larger sample need to be done to better understand RF/RHD pathogenesis.
Subject(s)
Biomarkers/blood , Pharyngitis/blood , Rheumatic Fever/blood , Rheumatic Heart Disease/blood , Adolescent , Adult , Aged , Antibodies/blood , Antistreptolysin/blood , Child , Child, Preschool , Cytokines/blood , Female , Host-Pathogen Interactions/genetics , Humans , India , Male , Mannose-Binding Lectin/blood , Middle Aged , Peptide Fragments/blood , Pharyngitis/genetics , Pharyngitis/microbiology , Pharyngitis/pathology , Procollagen/blood , Rheumatic Fever/genetics , Rheumatic Fever/microbiology , Rheumatic Fever/pathology , Rheumatic Heart Disease/genetics , Rheumatic Heart Disease/microbiology , Rheumatic Heart Disease/pathology , Streptococcus pyogenes/pathogenicityABSTRACT
We sequenced the genomes of 3,615 strains of serotype Emm protein 1 (M1) group A Streptococcus to unravel the nature and timing of molecular events contributing to the emergence, dissemination, and genetic diversification of an unusually virulent clone that now causes epidemic human infections worldwide. We discovered that the contemporary epidemic clone emerged in stepwise fashion from a precursor cell that first contained the phage encoding an extracellular DNase virulence factor (streptococcal DNase D2, SdaD2) and subsequently acquired the phage encoding the SpeA1 variant of the streptococcal pyrogenic exotoxin A superantigen. The SpeA2 toxin variant evolved from SpeA1 by a single-nucleotide change in the M1 progenitor strain before acquisition by horizontal gene transfer of a large chromosomal region encoding secreted toxins NAD(+)-glycohydrolase and streptolysin O. Acquisition of this 36-kb region in the early 1980s into just one cell containing the phage-encoded sdaD2 and speA2 genes was the final major molecular event preceding the emergence and rapid intercontinental spread of the contemporary epidemic clone. Thus, we resolve a decades-old controversy about the type and sequence of genomic alterations that produced this explosive epidemic. Analysis of comprehensive, population-based contemporary invasive strains from seven countries identified strong patterns of temporal population structure. Compared with a preepidemic reference strain, the contemporary clone is significantly more virulent in nonhuman primate models of pharyngitis and necrotizing fasciitis. A key finding is that the molecular evolutionary events transpiring in just one bacterial cell ultimately have produced millions of human infections worldwide.
Subject(s)
Epidemics , Evolution, Molecular , Genome, Bacterial/genetics , Streptococcal Infections/epidemiology , Streptococcal Infections/genetics , Streptococcus pyogenes/genetics , Streptococcus pyogenes/pathogenicity , Animals , Base Sequence , Disease Models, Animal , Fasciitis, Necrotizing/epidemiology , Fasciitis, Necrotizing/genetics , Fasciitis, Necrotizing/microbiology , Finland/epidemiology , Genes, Bacterial/genetics , Genomics , Humans , INDEL Mutation/genetics , Pharyngitis/epidemiology , Pharyngitis/genetics , Pharyngitis/microbiology , Polymorphism, Single Nucleotide/genetics , Primates/microbiology , Selection, Genetic , Serotyping , Streptococcal Infections/microbiology , Streptococcus pyogenes/isolation & purification , Time Factors , Virulence/geneticsABSTRACT
BACKGROUND: Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome is the most frequent repetitive fever syndrome in childhood. It is characterized by fever episodes lasting for approximately 3-6 days, once every 3-8 weeks. METHODS: Clinical and laboratory data for PFAPA syndrome patients between January 2010 and December 2014 followed up at a tertiary pediatric care hospital were reviewed. RESULTS: Four hundred children (256 male, 144 female; mean age at diagnosis, 4.2 ± 2.2 years), were enrolled in the study. During the episodes, mean leukocyte number was high (12 725/mm3 ) with predominant neutrophils. The mean number of monocytes was 1256/mm3 , and 90.2% had monocytosis. Serum amyloid A and C-reactive protein were high in 84.6% and in 77.8% of the patients, respectively. Mediterranean fever (MEFV) gene heterozygous mutation was identified in 57 of the 231 patients (24.7%) in whom genetic analysis had been performed. The most frequent mutation was heterozygous M694V (10%, n = 23). Extension of between-episode interval following prophylaxis was noted in 85% of those on regular colchicine treatment (n = 303). In the colchicine group, between-episode interval was prolonged from 18.8 ± 7.9 days (before colchicine treatment) to 49.5 ± 17.6 days on prophylactic colchicine therapy; also, prophylactic treatment was more effective in reducing episode frequency in patients with MEFV gene variant (n = 54, 96%) than in those without (n = 122, 80%; P = 0.003). CONCLUSIONS: This study has involved the largest number of PFAPA syndrome patients in the literature. It is particularly important to assess and to demonstrate the high rate of response to colchicine prophylaxis in PFAPA syndrome patients, especially those with MEFV variant. On blood screening, neutrophilia associated with monocytosis and low procalcitonin could contribute to diagnosis.
Subject(s)
Colchicine/therapeutic use , Familial Mediterranean Fever/drug therapy , Fever/prevention & control , Lymphadenitis/prevention & control , Pharyngitis/prevention & control , Stomatitis, Aphthous/prevention & control , Tubulin Modulators/therapeutic use , Child , Child, Preschool , Drug Administration Schedule , Familial Mediterranean Fever/diagnosis , Familial Mediterranean Fever/genetics , Female , Fever/diagnosis , Fever/genetics , Follow-Up Studies , Genetic Markers , Humans , Infant , Lymphadenitis/diagnosis , Lymphadenitis/genetics , Male , Mutation , Neck , Pharyngitis/diagnosis , Pharyngitis/genetics , Pyrin/genetics , Retrospective Studies , Stomatitis, Aphthous/diagnosis , Stomatitis, Aphthous/genetics , Syndrome , Treatment OutcomeABSTRACT
BACKGROUND: The cause and pathophysiology of PFAPA syndrome is unknown. The aim of this study was to determine all MEFV gene variants relevant to familial Mediterranean fever in children with PFAPA syndrome. METHODS: All MEFV gene variants were analyzed in patients with PFAPA syndrome. All patients were evaluated using the Gaslini scoring system. Serum immunoglobulin levels were also determined upon admission. RESULTS: We evaluated 64 patients with PFAPA syndrome. The median age at diagnosis was 37.5 (min-max: 6-96) months, and the percentage of male patients was 55.0%. The Gaslini diagnostic score for periodic fever was high in 81.0% of the patients. An MEFV gene mutation was found in 42 (66.0%) children. Mostly, heterozygous or compound heterozygous variants of the MEFV gene were found. Two patients were homozygous for R202Q. MEFV gene mutations were not detected in 22 (34.0%) patients. No significant differences in clinical or laboratory findings were observed between the two groups (p > 0.05), and there were no significant differences in period and duration of the fever episodes (p > 0.05). The fever of all 47 patients (100.0%) who received prednisolone during the episodes decreased within hours and did not recur. Eighteen of the patients using prednisolone underwent prophylaxis with colchicine, and the fever episodes of 9/18 (50.0%) patients using colchicine decreased within months. CONCLUSIONS: Most patients presenting with PFAPA syndrome have heterozygous MEFV gene mutations. Whether carrying a heterozygous MEFV gene is the primary cause of this syndrome requires further investigation.
Subject(s)
Cytoskeletal Proteins/genetics , Familial Mediterranean Fever/genetics , Lymphadenitis/genetics , Mutation , Pharyngitis/genetics , Stomatitis, Aphthous/genetics , Anti-Inflammatory Agents/therapeutic use , Biomarkers/blood , Child , Child, Preschool , Colchicine/therapeutic use , DNA Mutational Analysis , Familial Mediterranean Fever/blood , Familial Mediterranean Fever/diagnosis , Familial Mediterranean Fever/drug therapy , Female , Genetic Association Studies , Genetic Predisposition to Disease , Glucocorticoids/therapeutic use , Heterozygote , Homozygote , Humans , Immunoglobulin G/blood , Infant , Lymphadenitis/blood , Lymphadenitis/diagnosis , Lymphadenitis/drug therapy , Male , Pharyngitis/blood , Pharyngitis/diagnosis , Pharyngitis/drug therapy , Phenotype , Prednisolone/therapeutic use , Pyrin , Retrospective Studies , Risk Factors , Stomatitis, Aphthous/blood , Stomatitis, Aphthous/diagnosis , Stomatitis, Aphthous/drug therapy , Syndrome , Treatment OutcomeABSTRACT
BACKGROUND: Carriage of the HLA-Cw*0602 allele is associated with a particular set of clinical features and treatment responses in psoriasis. Tonsillectomy can improve psoriasis. OBJECTIVES: We sought to evaluate whether HLA-Cw*0602 predicts a favorable outcome after tonsillectomy of patients with psoriasis. METHODS: This prospective case series followed up 28 tonsillectomized patients with plaque psoriasis for 24 months. The Psoriasis Area and Severity Index, Psoriasis Disability Index, and Psoriasis Life Stress Inventory were used for assessment. Tonsils were swabbed for bacteria and patients genotyped for HLA-Cw*0602. RESULTS: After tonsillectomy, HLA-Cw*0602 homozygotes showed significantly more improvement, compared with heterozygous and HLA-Cw*0602-negative patients. Thus, Psoriasis Area and Severity Index score was reduced by 82% in the homozygous patients compared with 42% and 31%, respectively (P < .001), Psoriasis Disability Index score improved by 87% compared with 38% and 41%, respectively (P < .001), and Psoriasis Life Stress Inventory score was 82% reduced compared with 60% and 54%, respectively (P < .001). The homozygotes more often had psoriasis onset associated with a throat infection (P = .007) and an increased frequency of streptococcal throat infections per lifetime (P = .038). LIMITATIONS: Few patients were included and some data were retrospective. CONCLUSIONS: Homozygous HLA-Cw*0602 carriage in plaque psoriasis may predict a favorable outcome after tonsillectomy.
Subject(s)
HLA-C Antigens/genetics , Pharyngitis/genetics , Psoriasis/genetics , Streptococcal Infections/genetics , Tonsillectomy , Tonsillitis/genetics , Adult , Age of Onset , Alleles , Female , Follow-Up Studies , Humans , Male , Pharyngitis/complications , Pharyngitis/microbiology , Prognosis , Prospective Studies , Psoriasis/etiology , Severity of Illness Index , Streptococcal Infections/complications , Tonsillitis/complications , Tonsillitis/microbiology , Tonsillitis/surgery , Treatment Outcome , Young AdultABSTRACT
A 26-year-old woman presented with fever and pharyngitis. She previously experienced four periodic febrile episodes at 30- to 40-day intervals. We suspected periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome, and prescribed predisolone, thereby her fever rapidly subsided. Her febrile episodes improved after daily cimetidine treatment. Genetic testing results of genomic DNA for periodic fever syndromes were negative, although she was heterozygous for p.Glu148Gln variation in MEFV, supporting the diagnosis of PFAPA syndrome.
Subject(s)
Fever/diagnosis , Lymphadenitis/diagnosis , Pharyngitis/diagnosis , Stomatitis, Aphthous/diagnosis , Adult , Cimetidine/therapeutic use , Cytoskeletal Proteins/genetics , Female , Fever/drug therapy , Fever/genetics , Glucocorticoids/therapeutic use , Heterozygote , Humans , Japan , Lymphadenitis/drug therapy , Lymphadenitis/genetics , Pharyngitis/drug therapy , Pharyngitis/genetics , Prednisolone/therapeutic use , Pyrin , Stomatitis, Aphthous/drug therapy , Stomatitis, Aphthous/genetics , Syndrome , Treatment OutcomeABSTRACT
PFAPA syndrome is the most common autoinflammatory disorder in childhood with unknown etiology. The aim of our study was clinical evaluation of PFAPA patients from a single tertiary care center and to determine whether variations of AIM2, MEFV, NLRP3, and MVK genes are involved in PFAPA pathogenesis. Clinical and laboratory data of consecutive patients with PFAPA syndrome followed up at the University Children's Hospital, Ljubljana, were collected from 2008 to 2014. All four genes were PCR amplified and directly sequenced. Eighty-one patients fulfilled criteria for PFAPA syndrome, 50 (63%) boys and 31 (37%) girls, with mean age at disease onset of 2.1 ± 1.5 years. Adenitis, pharyngitis, and aphthae were present in 94%, 98%, and 56%, respectively. Family history of recurrent fevers in childhood was positive in 78%. Nineteen variants were found in 17/62 (27%) patients, 4 different variants in NLRP3 gene in 13 patients, and 6 different variants in MEFV gene in 5 patients, and 2 patients had 2 different variants. No variants of clinical significance were found in MVK and AIM2 genes. Our data suggest that PFAPA could be the result of multiple low-penetrant variants in different genes in combination with epigenetic and environmental factors leading to uniform clinical picture.
Subject(s)
Fever/genetics , Lymphadenitis/genetics , Pharyngitis/genetics , Stomatitis, Aphthous/genetics , Carrier Proteins/genetics , Child , Child, Preschool , Cytoskeletal Proteins/genetics , DNA-Binding Proteins/genetics , Female , Genetic Background , Humans , Infant , Longitudinal Studies , Male , Mutation , NLR Family, Pyrin Domain-Containing 3 Protein , Pyrin , SyndromeABSTRACT
BACKGROUND: PFAPA syndrome is a chronic disease that is characterized by recurrent episodes of high fever, aphthous stomatitis, pharyngitis, and cervical adenitis. Knowledge regarding the etiology of PFAPA is limited. OBJECTIVES: To provide up-to-date information considering etiology of PFAPA syndrome, by summarizing what has been explored and established in this area so far. MATERIALS AND METHODS: PubMed, Web of Science, and Scopus databases were searched for pertinent reports. Eventually 19 articles were selected. The results were classified into categories regarding three areas of interest: familial occurrence, genetic basis, and immunological mechanisms of PFAPA. RESULTS: Recent findings suggest that there is a familial tendency to PFAPA but the level of evidence does not warrant definite conclusions. The absence of a clear monogenic trait indicates a heterogenous, polygenic, or complex inheritance of PFAPA syndrome. As two mutations with a possible functional effect on the inflammasomes (MEFV E148Q and NLRP3 Q703K) have been found in several PFAPA cohorts, the role of inflammasome-related genes in PFAPA pathogenesis cannot be excluded. Immunological mechanisms of PFAPA involve an abnormal, IL-1ß dependent innate immune response to an environmental trigger, which leads to Th1-driven inflammation expressed by recruitment of T-cells to the periphery.
Subject(s)
Fever/immunology , Lymphadenitis/immunology , Pharyngitis/immunology , Stomatitis, Aphthous/immunology , Animals , Fever/genetics , Fever/pathology , Humans , Inflammation/genetics , Inflammation/immunology , Inflammation/pathology , Lymphadenitis/genetics , Lymphadenitis/pathology , Pharyngitis/genetics , Pharyngitis/pathology , Stomatitis, Aphthous/genetics , Stomatitis, Aphthous/pathologyABSTRACT
Periodic fever, aphthous stomatitis, pharyngitis and adenopathy (PFAPA) syndrome is an auto-inflammatory disease for which a genetic basis has been postulated. Nevertheless, in contrast to the other periodic fever syndromes, no candidate genes have yet been identified. By cloning, following long insert size paired-end sequencing, of a de novo chromosomal translocation t(10;17)(q11.2;p13) in a patient with typical PFAPA syndrome lacking mutations in genes associated with other periodic fever syndromes we identified SPAG7 as a candidate gene for PFAPA. SPAG7 protein is expressed in tissues affected by PFAPA and has been functionally linked to antiviral and inflammatory responses. Haploinsufficiency of SPAG7 due to a microdeletion at the translocation breakpoint leading to loss of exons 2-7 from one allele was associated with PFAPA in the index. Sequence analyses of SPAG7 in additional patients with PFAPA point to genetic heterogeneity or alternative mechanisms of SPAG7 deregulation, such as somatic or epigenetic changes.
Subject(s)
Antigens, Surface/genetics , Fever/genetics , Genetic Association Studies , Lymphatic Diseases/genetics , Pharyngitis/genetics , Stomatitis, Aphthous/genetics , Child , Child, Preschool , Chromosome Breakpoints , Female , Haploinsufficiency , Humans , Infant , Karyotyping , Male , Syndrome , Translocation, GeneticABSTRACT
PURPOSE: To investigate clinical presentation, genetic background and cytokine profile of Japanese sporadic cases of periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome. METHODS: Nine PFAPA syndrome patients were recruited. DNA sequence analysis of auto inflammatory disorder susceptibility genes, MEFV, MVK, NLRP3, and TNFRSF1A, were performed. Serum cytokine levels and monocyte IL-1ß levels were measured by ELISA. RESULTS: The study population consisted of six males and three females (mean age of onset 26.8 months). Febrile episodes lasted 3-6 days with symptom-free intervals ranging from 2 to 12 weeks. Fever was accompanied by pharyngitis (n = 8), aphthous stomatitis (n = 4), and cervical adenitis (n = 5). White blood cells and C-reactive protein were increased during the attack phase. Mean IgD serum levels were 7.32 ± 9.51 mg/dl during the attack phase, and were mildly elevated in two patients. Heterozygous MEFV, NLRP3 and TNFRSF1A variants were detected in four, one and three cases, respectively. Serum TNF-α and IL-18 levels were elevated during the attack-free and attack periods compared with controls. Other cytokines, IL-1ß, IL-1ra, IL-6, and sTNFR1, were only increased during the attack phase. Oral prednisolone was administered to eight patients and immediately reduced fever. Tonsillectomy performed in five patients induced cessation of fever in four patients. One case with repeated fever attacks after tonsillectomy showed increased monocyte IL-1ß production, similar to the other active case with genetic variants of auto inflammatory disorder-associated genes. CONCLUSIONS: Japanese PFAPA syndrome patients may have cytokine regulation dysfunction as a result of genetic variants of auto inflammatory disorder-associated genes.